The investigation of prooxidant-antioxidant balance in serum of children with family histories of essential hypertension

Research Communications in Molecular Pathology and Pharmacology

Volumn 111, Issue 1-4, 2002, Pages 167-174

  Öztezcan, Serdar ^a,b   Doǧru Abbasoǧlu, Semra ^a   Mutlu Türkoǧlu, Ümit ^a   Çetiner, Selma ^a   Eker Ömeroǧlu, Rukiye ^a   Aykaç Toker, Gülçin ^a   Uysal, Müjdat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antioxidant activity; Children; Essential hypertension; Glutathione peroxidase; Lipid peroxidation; Selenium; VLDL+LDL peroxidation

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN B; GLUTATHIONE PEROXIDASE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZING AGENT; SELENIUM; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MALE; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SPECTROFLUOROMETRY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHILD; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERTENSION; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MALONDIALDEHYDE; REACTIVE OXYGEN SPECIES; SELENIUM;

EID: 0141671872     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alexander RW (1995). Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflamatory response: A new perspective. Hypertension 25: 155-161.
2. Djordjevik VB, Pavlovic D, Pejovic M, Cvetkovic T, Lecic N, Deljanin-Ilic M (1997). Changes of lipid, peroxides and antioxidative factor levels in blood of patients treated with ACE inhibition. Clin Nephrol 47: 243-247.
3. Gugliuchi A, Menini T, Stahl AJC (1994). Susceptibilty to copper-enhanced autoxidation of VLDL-LDL fractions from diabetic patients. Biochem Mol Biol Int 32: 139-147.
4. Keidar S, Kaplan M, Shapira C, Brook VG, Aviram M (1994). Low density lipoprotein isolated from patients with essential hypertension exihibit increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis; 107: 71-84.
5. Kumar KW, Das UN (1993). Are free radicals invoved in the pathobiology of human essential hypertension. Free Radical Res Commun 19: 59-66.
6. Lacy F, O'Connor DT, Schmid-Schonbein GW (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16:291-303.
7. Maggi E, Marchesi E, Ravetta V, Falaschi F, Finardi G, Bellomo G (1993). Low-density lipoprotein oxidaiton in essential hypertension. J Hypertens 11: 1103-1111.
8. Maggi E, Marchesi E, Ravetta V, Martignon A, Finardi G, Bellomo G (1995). Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypertens 13: 129-138.
9. Miller NS, Rice-Evans CA (1996). Spectrophotometric determination of antioxidant activity. Redox Report 2: 161-171.
10. Moore JA, Noiva R, Wells IC.: Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis. Clin Chem 1984; 30: 1171-1173.
11. Ness AR, Khaw KT, Bingham S, Day NE (1996). Vitamin C status and blood pressure. J Hypertens 14: 503-508.
12. Özdemirler G, Mehmetcik G, Öztezcan S, Toker G, Sivas A, Uysal M (1995). Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocard infarction. Horm Metab Res 27: 194-196.
13. Paglia DE, Valentine WN (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169.
14. Parik T, Allikmets K, Teesalu R, Zilmer M (1996). Oxidative stress and hyperinsulinemia in essential hypertension: different facets of increased risk. J Hypertens 14: 407-410.
15. Romeo-Alvira D, Roche A (1996). High blood pressure, oxygen radicals and antioxidants: etiological relationship. Med Hypothesis 46: 414-420.
16. Russo C, Olivieri D, Girelli D, Faccini G, Zenari ML, Lombardi S et al. (1998). Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16: 1267-1271.
17. Schwenke DC (1998). Antioxidants and atherogenesis. J Nutr Biochem 9: 424-445.
18. Srinivasan KN, Pugalendi KV, Sambandam G, Rao MR, Krishan S, Menon VP (1998). Comparison of glicoprotein components, tryptophan, lipid peroxidation and antioxidants in borderline and severe hypertension and myocardial infarction. Clin Chim Acta 275: 197-203.
19. Steinberg D (1997). Oxidative modification of LDL and atherogenesis. Circulation 95: 1062-1071.
20. Szamosi T, Gara I, Venekei I, Javor A, Ceskel R, Knoll J (1987). Serum lipids, lipid peroxides and the care of children with high risk atherosclerotic family history. Atherosclerosis 68: 111-115.
21. Uysal M, Bulur H, Sener D, Öz H (1986). Lipid peroxidation in patients with essential hypertension. Int J Clin Pharmacol Ther Toxicol 24: 474-476.
22. Wasowicz W, Néve J, Peretz A (1993). Optimized steps in fluorometric determination of thiobarbituric acid-reactive substance in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem 39: 2522-2526.